{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:37:41Z","timestamp":1787002661630,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cognitive deficits in individuals at risk of psychosis represent a significant challenge for research, as current strategies for symptomatic treatment are often ineffective. Recent studies showed that atypical cognitive development predicts the occurrence of psychotic symptoms. Additionally, abnormal brain development is known to predate clinical manifestations of psychosis. Therefore, critical developmental stages may be the best period for early interventions expected to prevent cognitive decline and protect brain maturation. However, it is challenging to identify and treat individuals at risk of psychosis in the general population before the onset of the first psychotic symptoms. 22q11.2 deletion syndrome (22q11DS), the neurogenetic disorder with the highest genetic risk for schizophrenia, provides the opportunity to prospectively study the development of subjects at risk for psychosis. In this retrospective cohort study, we aimed to establish if early treatment with SSRIs in children and adolescents with 22q11DS was associated with long-term effects on cognition and brain development. We included 98 participants with a confirmed diagnosis of 22q11DS followed up 2\u20134 times (age range: 10\u201332). Thirty subjects without psychiatric disorders never received psychotropic medications, thirty had psychotic symptoms but were not treated with SSRIs, and 38 received SSRIs treatment. An increase in IQ scores characterized the developmental trajectories of participants receiving treatment with SSRIs, even those with psychotic symptoms. The thickness of frontal regions and hippocampal volume were also relatively increased. The magnitude of the outcomes was inversely correlated to the age at the onset of the treatment. We provide preliminary evidence that early long-term treatment with SSRIs may attenuate the cognitive decline associated with psychosis in 22q11DS and developmental brain abnormalities.<\/jats:p>","DOI":"10.1038\/s41398-021-01456-x","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T12:05:03Z","timestamp":1622289903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4411-896X","authenticated-orcid":false,"given":"Valentina","family":"Mancini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Bortolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Schaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Eliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"1456_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature09552","volume":"468","author":"TR Insel","year":"2010","unstructured":"Insel, T. R. Rethinking schizophrenia. Nature 468, 187\u2013193 (2010).","journal-title":"Nature"},{"key":"1456_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4088\/JCP.0706e03","volume":"67","author":"MF Green","year":"2006","unstructured":"Green, M. F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J. Clin. Psychiatry 67, 3\u20138 (2006).","journal-title":"J. Clin. Psychiatry"},{"key":"1456_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1176\/appi.ajp.2020.20020147","volume":"177","author":"RS Kahn","year":"2020","unstructured":"Kahn, R. S. On the Origins of Schizophrenia. Am. J. Psychiatry 177, 291\u2013297 (2020).","journal-title":"Am. J. Psychiatry"},{"key":"1456_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/appi.ajp.2009.09040574","volume":"167","author":"A Reichenberg","year":"2010","unstructured":"Reichenberg, A. et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: A 30-year study. Am. J. Psychiatry 167, 160\u2013169 (2010).","journal-title":"Am. J. Psychiatry"},{"key":"1456_CR5","doi-asserted-by":"crossref","unstructured":"Dickinson D., Giangrande E. J., Eisenberg D. P., Gregory M. D. & Berman K. F. Distinct polygenic score profiles in schizophrenia subgroups with different trajectories of cognitive development. Am J Psychiatry. 177, 298\u2013307 (2020).","DOI":"10.1176\/appi.ajp.2019.19050527"},{"key":"1456_CR6","doi-asserted-by":"crossref","unstructured":"Mukherjee A., Carvalho F., Eliez S. & Caroni P. Long-lasting rescue of network and cognitive dysfunction in a genetic schizophrenia model article long-lasting rescue of network and cognitive dysfunction. Cell. 178, 1387-1402.e14 (2019).","DOI":"10.1016\/j.cell.2019.07.023"},{"key":"1456_CR7","doi-asserted-by":"publisher","unstructured":"Sun D. et al. Fluoxetine administration during adolescence attenuates cognitive and synaptic deficits in adult 3\u00d7TgAD mice. Neuropharmacology https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.037 (2017).","DOI":"10.1016\/j.neuropharm.2017.08.037"},{"key":"1456_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","volume":"171","author":"M Schneider","year":"2015","unstructured":"Schneider, M. et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 deletion syndrome. Am. J. Psychiatry 171, 627\u2013639 (2015).","journal-title":"Am. J. Psychiatry"},{"key":"1456_CR9","doi-asserted-by":"publisher","unstructured":"Tang S. X. et al. The psychosis spectrum in 22q11.2 deletion syndrome is comparable to that of nondeleted youths. Biol Psychiatry https:\/\/doi.org\/10.1016\/j.biopsych.2016.08.034 (2017).","DOI":"10.1016\/j.biopsych.2016.08.034"},{"key":"1456_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/wps.20347","volume":"15","author":"M Schneider","year":"2016","unstructured":"Schneider, M. et al. Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome. World Psychiatry 15, 259\u2013265 (2016).","journal-title":"World Psychiatry"},{"key":"1456_CR11","doi-asserted-by":"publisher","unstructured":"Sun D. et al. Large-scale mapping of cortical alterations in 22q11. 2 deletion syndrome: convergence with idiopathic psychosis and effects of deletion size. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-018-0078-5 (2017).","DOI":"10.1038\/s41380-018-0078-5"},{"key":"1456_CR12","doi-asserted-by":"publisher","unstructured":"Cleynen I. et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11. 2 deletion. Mol. Psichiatr. https:\/\/doi.org\/10.1038\/s41380-020-0654-3 (2020).","DOI":"10.1038\/s41380-020-0654-3"},{"key":"1456_CR13","first-page":"1","volume":"380","author":"JR Zinkstok","year":"2019","unstructured":"Zinkstok, J. R. et al. Neurobiological perspective of 22q11. 2 deletion syndrome. Lancet Psychiatry 380, 1\u201310 (2019).","journal-title":"Lancet Psychiatry"},{"key":"1456_CR14","doi-asserted-by":"crossref","unstructured":"Vorstman J. A. S. et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry 72, 377\u2013385 (2015).","DOI":"10.1001\/jamapsychiatry.2014.2671"},{"key":"1456_CR15","doi-asserted-by":"crossref","unstructured":"Padula M. C. et al. Cortical morphology development in patients with 22q11. 2 deletion syndrome at ultra-high risk of psychosis. Psychol. Med. 48, 2375\u20132383 (2019).","DOI":"10.1017\/S0033291717003920"},{"key":"1456_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biopsych.2014.10.025","volume":"78","author":"JE Schmitt","year":"2015","unstructured":"Schmitt, J. E. et al. Archival report aberrant cortical morphometry in the 22q11. 2 deletion syndrome. Biol. Psychiatry 78, 135\u2013143 (2015).","journal-title":"Biol. Psychiatry"},{"key":"1456_CR17","doi-asserted-by":"crossref","unstructured":"Chow E. W. C. et al. Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus. Am J Psychiatry. 168, 522\u2013529 (2011).","DOI":"10.1176\/appi.ajp.2010.10081230"},{"key":"1456_CR18","doi-asserted-by":"crossref","unstructured":"Ching C. R. K. et al. Mapping subcortical brain alterations in 22q11. 2 deletion syndrome: effects of deletion size and convergence with idiopathic neuropsychiatric illness. Am J Psychiatry. 177, 589\u2013600 (2020).","DOI":"10.1176\/appi.ajp.2019.19060583"},{"key":"1456_CR19","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1038\/s41380-019-0443-z","volume":"25","author":"V Mancini","year":"2020","unstructured":"Mancini, V. et al. Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS. Mol. Psychiatry 25, 2844\u20132859 (2020).","journal-title":"Mol. Psychiatry"},{"key":"1456_CR20","first-page":"875","volume":"5","author":"V Mancini","year":"2020","unstructured":"Mancini, V., Z\u00f6ller, D., Schneider, M., Schaer, M. & Eliez, S. Abnormal development and dysconnectivity of distinct thalamic nuclei in patients with 22q11.2 deletion syndrome experiencing auditory hallucinations. Biol. Psychiatry Cogn. Neurosci. Neuroimaging. 5, 875\u2013890 (2020).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging."},{"key":"1456_CR21","doi-asserted-by":"crossref","unstructured":"Lett T. A., Voineskos A. N., Kennedy J. L., Levine B. & Daskalakis J. Treating working memory deficits in schizophrenia: a review of the neurobiology. Biol Psychiatry. 75, 361\u2013370. (2014).","DOI":"10.1016\/j.biopsych.2013.07.026"},{"key":"1456_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.schres.2004.09.008","volume":"72","author":"JM Gold","year":"2004","unstructured":"Gold, J. M. Cognitive deficits as treatment targets in schizophrenia. Schizophr. Res. 72, 21\u201328 (2004).","journal-title":"Schizophr. Res."},{"key":"1456_CR23","doi-asserted-by":"crossref","unstructured":"Roberts C., Sahakian B. J. & Robbins T. W. Psychological mechanisms and functions of 5-HT and SSRIs in potential therapeutic change: lessons from the serotonergic modulation of action selection, learning, affect, and social cognition. Neurosci Biobehav Rev. 119, 138-167 (2020).","DOI":"10.1016\/j.neubiorev.2020.09.001"},{"key":"1456_CR24","doi-asserted-by":"crossref","unstructured":"Santarelli L. et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805\u2013809 (2003).","DOI":"10.1126\/science.1083328"},{"key":"1456_CR25","doi-asserted-by":"crossref","unstructured":"Boldrini M. et al. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34, 2376\u20132389 (2009).","DOI":"10.1038\/npp.2009.75"},{"key":"1456_CR26","doi-asserted-by":"crossref","unstructured":"Chottekalapanda R. U. et al. AP-1 controls the p11-dependent antidepressant response. Mol. Psychiatry 25,1364\u20131381 (2020).","DOI":"10.1038\/s41380-020-0767-8"},{"key":"1456_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1150516","volume":"320","author":"JFM Vetencourt","year":"2008","unstructured":"Vetencourt, J. F. M. et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 320, 385\u2013388 (2008).","journal-title":"Science"},{"key":"1456_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1460-9568.2010.07488.x","volume":"33","author":"JFM Vetencourt","year":"2011","unstructured":"Vetencourt, J. F. M., Tiraboschi, E., Spolidoro, M., Castr\u00e9n, E. & Maffei, L. Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats. Eur. J. Neurosci. 33, 49\u201357 (2011).","journal-title":"Eur. J. Neurosci."},{"key":"1456_CR29","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1523\/JNEUROSCI.3287-12.2012","volume":"32","author":"E Castr\u00e9n","year":"2012","unstructured":"Castr\u00e9n, E., Elgersma, Y., Maffei, L. & Hagerman, R. Treatment of neurodevelopmental disorders in adulthood. J. Neurosci. 32, 14074\u201314079 (2012).","journal-title":"J. Neurosci."},{"key":"1456_CR30","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1111\/ejn.14512","volume":"50","author":"A Steinzeig","year":"2019","unstructured":"Steinzeig, A., Cannarozzo, C. & Castr\u00e9n, E. Fluoxetine-induced plasticity in the visual cortex outlasts the duration of the naturally occurring critical period. Eur. J. Neurosci. 50, 3663\u20133673 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"1456_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.euroneuro.2007.07.001","volume":"18","author":"S Monle\u00f3n","year":"2008","unstructured":"Monle\u00f3n, S., Vinader-Caerols, C., Arenas, M. C. & Parra, A. Antidepressant drugs and memory: Insights from animal studies. Eur. Neuropsychopharmacol. 18, 235\u2013248 (2008).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1456_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/YIC.0000000000000070","volume":"30","author":"H Silver","year":"2015","unstructured":"Silver, H. et al. Improvement in verbal memory following SSRI augmentation of antipsychotic treatment is associated with changes in the expression of mRNA encoding for the GABA-A receptor and BDNF in PMC of schizophrenic patients. Int. Clin. Psychopharmacol. 30, 158\u2013166 (2015).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"1456_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1192\/bjp.bp.109.067710","volume":"197","author":"SP Singh","year":"2010","unstructured":"Singh, S. P., Singh, V., Kar, N. & Chan, K. Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: Meta-analysis. Br. J. Psychiatry 197, 174\u2013179 (2010).","journal-title":"Br. J. Psychiatry"},{"key":"1456_CR34","doi-asserted-by":"crossref","unstructured":"Bartlett E. A. et al. Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder. Neuropsychopharmacology 43, 2221\u20132230 (2018).","DOI":"10.1038\/s41386-018-0122-9"},{"key":"1456_CR35","doi-asserted-by":"crossref","unstructured":"Phillips J. L., Batten L. A., Tremblay P., Aldosary F. & Blier P. A prospective, longitudinal study of the effect of remission on cortical thickness and hippocampal volume in patients with treatment-resistant depression. Int. J. Neuropsychopharmacol. 18, pyv037 (2015).","DOI":"10.1093\/ijnp\/pyv037"},{"key":"1456_CR36","doi-asserted-by":"crossref","unstructured":"Kong L. et al. Frontal-subcortical volumetric deficits in single episode, medication-na\u00efve depressed patients and the effects of 8 weeks fluoxetine treatment:A VBM-DARTEL study. PLoS ONE. 9, e79055 (2014).","DOI":"10.1371\/journal.pone.0079055"},{"key":"1456_CR37","unstructured":"Weschler D. Wechsler Adult Intelligence Scale-IV: administration and scoring manual (Psychological Corporation, 2011)."},{"key":"1456_CR38","doi-asserted-by":"crossref","unstructured":"Weschler D. The Wechsler intelligence scale for children, 4th edn (Pearson Assesment, 2004).","DOI":"10.1037\/t15174-000"},{"key":"1456_CR39","unstructured":"Conners C. K. & MHS Staff. Conners Continuous Performance Test,3rd edn, Technical manual. (Multi-Health Systems, 2014)."},{"key":"1456_CR40","doi-asserted-by":"crossref","unstructured":"Reich W. Diagnostic interview for children and adolescents (DICA). J Am Acad Child Adolesc Psychiatry. 39: 59\u201366 (2000).","DOI":"10.1097\/00004583-200001000-00017"},{"key":"1456_CR41","doi-asserted-by":"crossref","unstructured":"Gorgens K. A. Structured clinical interview For DSM-IV (SCID-I\/SCID-II). Encycl Clin Neuropsychol. New York, NY: Springer New York, pp 2410\u20132417 (2011).","DOI":"10.1007\/978-0-387-79948-3_2011"},{"key":"1456_CR42","doi-asserted-by":"crossref","unstructured":"Miller T. J. et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 29, 703\u2013716 (1995).","DOI":"10.1093\/oxfordjournals.schbul.a007040"},{"key":"1456_CR43","unstructured":"T. M. A. Manual for the Child Behavior Checklist\/4-18 and 1991 Profile (Univ Vermont Dep Psychiatry, Burlington, NJ., 1992)."},{"key":"1456_CR44","unstructured":"Achenbach, T. M. & Rescorla, L. A. Manual for the ASEBA Adult Forms & Profiles (Univ Vermont, Res Cent Child Youth, Fam Burlington, VT, 2003)."},{"key":"1456_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale, A. M., Fischl, B. & Sereno, M. I. Cortical surface-based analysis. Neuroimage 9, 195\u2013207 (1999).","journal-title":"Neuroimage"},{"key":"1456_CR46","doi-asserted-by":"publisher","unstructured":"Iglesias J. E. et al. A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI. Neuroimage https:\/\/doi.org\/10.1016\/j.neuroimage.2015.04.042 (2015).","DOI":"10.1016\/j.neuroimage.2015.04.042"},{"key":"1456_CR47","doi-asserted-by":"crossref","unstructured":"Fischl B. & Dale A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl Acad. Sci. USA 97, 11050\u201311055 (2000).","DOI":"10.1073\/pnas.200033797"},{"key":"1456_CR48","doi-asserted-by":"crossref","unstructured":"Desikan R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968\u2013980 (2006).","DOI":"10.1016\/j.neuroimage.2006.01.021"},{"key":"1456_CR49","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuroimage.2013.05.076","volume":"82","author":"AK Mutlu","year":"2013","unstructured":"Mutlu, A. K. Sex differences in thickness, and folding developments throughout the cortex. Neuroimage 82, 200\u2013207 (2013).","journal-title":"Neuroimage"},{"key":"1456_CR50","doi-asserted-by":"crossref","unstructured":"Franchini M. et al. Early adaptive functioning trajectories in preschoolers with autism spectrum disorders. J. Pediatr. Psychol. 43, 800\u2013813 (2018).","DOI":"10.1093\/jpepsy\/jsy024"},{"key":"1456_CR51","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4088\/JCP.v64n0607","volume":"64","author":"S Woods","year":"2003","unstructured":"Woods, S. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 64, 663\u2013667 (2003).","journal-title":"J. Clin. Psychiatry"},{"key":"1456_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","volume":"180","author":"Y Hayasaka","year":"2015","unstructured":"Hayasaka, Y. et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J. Affect Disord. 180, 179\u2013184 (2015).","journal-title":"J. Affect Disord."},{"key":"1456_CR53","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1002\/hbm.22576","volume":"35","author":"SK Krogsrud","year":"2014","unstructured":"Krogsrud, S. K. et al. Development of hippocampal subfield volumes from 4 to 22 years. Hum. Brain Mapp. 35, 5646\u20135657 (2014).","journal-title":"Hum. Brain Mapp."},{"key":"1456_CR54","doi-asserted-by":"publisher","unstructured":"Fossati P., Radtchenko A., Boyer P. Neuroplasticity: from mri to depressive symptoms. Eur. Neuropsychopharmacol. https:\/\/doi.org\/10.1016\/j.euroneuro.2004.09.001 (2004).","DOI":"10.1016\/j.euroneuro.2004.09.001"},{"key":"1456_CR55","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/npp.2013.2","volume":"38","author":"K Ohira","year":"2013","unstructured":"Ohira, K., Takeuchi, R., Shoji, H. & Miyakawa, T. Fluoxetine-induced cortical adult neurogenesis. Neuropsychopharmacology 38, 909\u2013920 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1456_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-019-0489-5","volume":"12","author":"K Ohira","year":"2019","unstructured":"Ohira, K., Hagihara, H., Miwa, M., Nakamura, K. & Miyakawa, T. Fluoxetine-induced dematuration of hippocampal neurons and adult cortical neurogenesis in the common marmoset. Mol. Brain 12, 1\u201310 (2019).","journal-title":"Mol. Brain"},{"key":"1456_CR57","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/nrn2513","volume":"9","author":"T Paus","year":"2008","unstructured":"Paus, T., Keshavan, M. & Giedd, J. N. Why do many psychiatric disorders emerge during adolescence? Nat. Rev. Neurosci. 9, 947\u2013957 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"1456_CR58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.neuroimage.2011.11.080","volume":"61","author":"SJ Blakemore","year":"2012","unstructured":"Blakemore, S. J. Imaging brain development: the adolescent brain. Neuroimage 61, 397\u2013406 (2012).","journal-title":"Neuroimage"},{"key":"1456_CR59","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/S0140-6736(12)60072-5","volume":"379","author":"SM Sawyer","year":"2012","unstructured":"Sawyer, S. M. et al. Adolescence: a foundation for future health. Lancet 379, 1630\u20131640 (2012).","journal-title":"Lancet"},{"key":"1456_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/npp.2009.115","volume":"35","author":"GZ Tau","year":"2010","unstructured":"Tau, G. Z. & Peterson, B. S. Normal development of brain circuits. Neuropsychopharmacology 35, 147\u2013168 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"1456_CR61","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.biopsych.2006.03.082","volume":"59","author":"A Dranovsky","year":"2006","unstructured":"Dranovsky, A. & Hen, R. Hippocampal Neurogenesis: Regulation by Stress and Antidepressants. Biol. Psychiatry 59, 1136\u20131143 (2006).","journal-title":"Biol. Psychiatry"},{"key":"1456_CR62","first-page":"1","volume":"14","author":"T Yang","year":"2020","unstructured":"Yang, T. et al. The role of BDNF on neural plasticity in depression. Front Cell Neurosci. 14, 1\u201312 (2020).","journal-title":"Front Cell Neurosci."},{"key":"1456_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"MJF Levy","year":"2019","unstructured":"Levy, M. J. F. et al. 5-HTT independent effects of fluoxetine on neuroplasticity. Sci. Rep. 9, 1\u201311 (2019).","journal-title":"Sci. Rep."},{"key":"1456_CR64","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto, P. C. et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 184, 1299\u20131313 (2021). e19.","journal-title":"Cell"},{"key":"1456_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3379","volume":"14","author":"H Park","year":"2013","unstructured":"Park, H. & Poo, M. M. Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 14, 7\u201323 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"1456_CR66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/cap.2014.0075","volume":"27","author":"N Dori","year":"2017","unstructured":"Dori, N., Green, T., Weizman, A. & Gothelf, D. The effectiveness and safety of antipsychotic and antidepressant medications in individuals with 22q11.2 deletion syndrome. J. Child Adolesc. Psychopharmacol. 27, 83\u201390 (2017).","journal-title":"J. Child Adolesc. Psychopharmacol."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01456-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T08:14:44Z","timestamp":1669882484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01456-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01456-x","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"336"}}